Abstract. MicroRNAs (miRNAs) are non-coding small RNAs that regulate cell proliferation and functions by interfering with the translation of target mRNAs. Altered expression of miRNA is known to induce various human malignancies. We examined the expression of miRNAs in squamous cell carcinoma of human head and neck (HNSCC) and esophagus (ESCC), compared to that in normal squamous epithelia as well as malignancies of other organs. Microarray analysis showed up-regulation of miR-21, miR-16 and miR-30a-5p in HNSCC and ESCC cell lines compared to normal squamous epithelial cell lines, and consistent high expression of miR-205 and let-7a in both normal and malignant squamous epithelial cell lines. Validation study using real-time quantitative RT-PCR in formalin-fixed paraffin-embedded cancer tissues and paired normal epithelia obtained by Laser-captured microdissection revealed that miR-205 showed highest expression in both malignant and benign squamous epithelia, although it was less expressed in cell lines and tissues other than squamous epithelia. MiR-21, which is an oncogenic miRNA in various malignancies, was also up-regulated in HNSCC and ESCC compared to paired normal squamous epithelia. These results suggest that miR-205 might be a specific marker miRNA of both normal and malignant squamous epithelia, while miR-21 might be a putative oncogenic miRNA in HNSCC and ESCC.
Introduction
Squamous cell carcinoma (SCC) is the most common malignant tumor in the head and neck region and the esophagus (1-3). While the incidence and mortality of the esophageal SCC (ESCC) has been gradually declining due to significant advances in surgery and radiotherapy over the last decades (1), those of head and neck SCC (HNSCC) is still increasing despite intense efforts, and its 5-year survival rates is less than 50% (2, 3) . To further improve outcomes of the patients with HNSCC and ESCC, novel diagnostic, therapeutic and prognostic biomarkers should be developed.
MicroRNAs (miRNAs) are non-coding small RNAs (~22 nucleotides) that regulate posttranscriptional gene expression by interfering with the translation of target mRNA (4, 5) . One miRNA may regulate the expression of several genes and over one-third of all protein-coding genes may be under translational control by miRNAs (5) . MiRNAs are involved in a variety of cellular processes, including the regulation of cellular differentiation, proliferation and apoptosis (5) . Aberrant expression of miRNA is known to induce various human malignancies (6) (7) (8) (9) and they are clearly classified by miRNA expression profiles (9, 10) . MiR-21 functions as a putative oncogenic miRNA in brain and breast cancers by indirectly down-regulating the anti-apoptotic gene BCL2, while miR-16 and let-7a act as tumor-suppressive miRNAs in B-cell lymphomas and colorectal carcinomas by directly up-regulating the translation of BCL2 and RAS oncogenes, respectively (6) (7) (8) (9) . MiR-205 was originally identified as an miRNA up-regulated in HNSCC cell lines (11) .
In this study, we examined the expression of miRNAs in human HNSCC and ESCC, compared to those in normal squamous epithelia and malignancies of other organs. Two potential biomarker miRNAs for HNSCC and ESCC (miR-21) and squamous epithelia (miR-205) were identified by microarray analysis and following validation by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) using formalin-fixed paraffin-embedded (FFPE) tissue samples obtained by Laser-captured micro-dissection (LCM). We also discuss the application of miRNA qRT-PCR ONCOLOGY REPORTS 23: 1625 -1633 , 2010 Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC Microarray analysis. Total RNAs from cultured cell lines were extracted by TRIzol™ reagent (Gibco Invitrogen) and quantified with NanoDrop™ spectrometer (NanoDrop Technology, Wilmington, DL, USA). The quality was checked by Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), in order to assure that the RNA lacked DNA contamination and that the RNA was not degraded. MiRNAs were further purified from total RNAs by flash PAGE™ system (Applied Biosystems, Foster City, CA, USA) and labeled with mirVana™ miRNA Labeling kit (Applied Biosystems). MiRNA microarray analysis was performed by Filgen Inc. (Nagoya, Japan) using mirVana miRNA Bioarray V2 (Applied Biosystems), which contains 662 mature and pre-miRNAs including 328 human miRNAs. The arrays run were then scanned by GenePix™ 4000B scanner (Molecular Devices Corp., Sunnyvale, CA, USA) and their images were analyzed with Array-Pro™ Analyzer Ver.4.5 (Media Cybernetics Inc., Bethesda, MD, USA). Each microarray assay was performed three times using different sets of miRNA extracts and quantile normalization was performed. Reverse transcription was performed in the following conditions; 16˚C for 30 min, 42˚C for 30 min, 85˚C for 5 min with a sample volume of 15 μl (TaqMan MicroRNA Assays) or 37˚C for 60 min, then 95˚C for 5 min with a sample volume of 20 μl (miScript PCR System). The real-time PCR was performed as follows; 50˚C for 2 min, 95˚C for 10 min, 40 cycles of 95˚C for 15 sec and 60˚C for 1 min with a sample volume of 20 μl (TaqMan MicroRNA Assays) or 95˚C for 15 min, 40 cycles of 94˚C for 15 sec and 55˚C for 30 sec, and 70˚C for 30 sec with a sample volume of 20 μl (miScript PCR System). The expression level was normalized to the U6 expression used as an inner control and was determined by the following processes; the average C t of the inner control (C t inner ) and the sample C t were determined. This value was then entered into this formula = 2 -(Ct-Ct inner) . The average miRNA expression in normal tissue vs. malignant tissue was determined by the Mann-Whitney's U test using the MEDCALC software program (MedCalc software, Mariakerke, Belgium). A p-value <0.05 was considered to be significant. The values were expressed as the mean with standard errors (SE). To clarify whether miRNA was correctly amplified, RT-PCR products were separated with and cut from 4% agarose gel and the DNA was extracted and cloned into pCR II vector (Gibco Invitorogen). Nucleotide sequencing was performed using ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
Results

Expression of miRNAs in sqaumous epithelial cell lines by microarray analysis.
For miRNA microarray analysis of human HNSCC and ESCC, we prepared 4 sets of miRNA extracts. The HNSCC set consisted of a mixture of equal amounts of miRNAs derived from 6 tongue SCC cell lines (SCC4, SCC9, SCC15, SCC25, OSC19 and OSC20), while the ESCC set consisted of those from 7 ESCC cell lines (KYSE30, KYSE70, KYSE140, KYSE170, KYSE180, KYSE220 and KYSE270). Human normal oral or esophageal squamous epithelial cell set consisted only of HOK or HEEC cell line, respectively. Each microarray assay was performed three times using different sets of miRNA extracts, and the results were averaged and normalized with inner controls. The 12 most highly expressed miRNAs in 4 sets of microarrays are listed in Table I . Net intensities of miR-205 showed highest expression in all 4 sets examined, and those of miR-21 showed second highest expression in HNSCC and ESCC sets and third highest expression in normal squamous epithelial sets. Four miRNAs let-7a, miR-23a, miR-23b and miR-200c were also shown to be expressed abundantly in all 4 sets. We also ONCOLOGY REPORTS 23: 1625 -1633 , 2010 Table I. The 12 highest expressions (net intensity) of miRNAs in malignant and benign squamous epithelial cell lines by miRNA microarray. 
Each value is shown in net intensity after quantile normalization. Table II . Differential expression of miRNAs in malignant and benign squamous epithelial cell lines by statistical analysis of miRNA microarray. 
Each value is shown in net intensity after quantile normalization. Brackets indicate fold increases compared to the intensity in HOK or HEEC. Table III . Patient profiles, location and histological differentiation of FFPE tissue samples used in this study. ----------------------------------------------------------------------------------------------------- examined differentially expressed miRNAs between benign and malignant squamous epithelial sets. Significantly up-or down-regulated miRNAs in HNSCC and ESCC sets compared to corresponding normal squamous epithelial sets are listed in Table II . MiR-30a-5p, miR-21, miR-16 and miR-107 were up-regulated in both HNSCC and ESCC sets, while no miRNAs were commonly down-regulated in these sets. Among these highly and/or differentially expressed miRNAs, we selected miR-205, miR-21, let-7a and miR-16 in the next step of validation study, because former four miRNAs showed not only up-regulation but also high level expression both in HNSCC and ESCC, and their functions including target mRNAs have been widely studied in malignancies of other organs (6-9). MiR-30a-5p was also subjected to the validation study, although its specific expression or function remains unclear.
Validation of miRNA expression by real-time qRT-PCR.
In order to validate the miRNA expression profiles of HNSCC and ESCC by microarray analysis, we performed real-time qRT-PCR for various cancer cell lines and FFPE tissue samples. Patient profiles, location, histological differentiation of FFPE tissue samples are summarized in Table III . First, we examined relative expression of miR-205, miR-21, let-7a and miR-16 in 9 tongue SCC cell lines, 8 ESCC cell lines, 1 hepatocellular carcinoma cell line, 3 hematological cancer cell lines, 3 colorectal adenocarcinoma cell lines, and 7 normal oral squamous epithelia from frozen sections obtained by LCM. As shown in Fig. 1 , consistent high expression (net intensity) of miR-205 was observed in all SCC cell lines as well as normal squamous epithelia, whereas no detectable level of the expression was observed in non-sqaumous epithelial cell lines (1 hepatocellular, 3 hematological and 3 colorectal cancer cell lines). MiR-21, let-7a and miR-16 were also highly expressed and up-regulated in SCC cell lines compared to normal squamous epithelia (p<0.05). These results suggested that miR-205 could be a specific marker of squamous epithelium, and miR-21, let-7a and miR-16 could be up-regulated in HNSCC and ESCC. In further validation, we next examined the expression of these 4 miRNAs and miR-30a-5p in clinical samples. In preliminary experiments, we confirmed that high-quality miRNAs detectable in RT-PCR were extracted from FFPE tissues stored over 20 years and the nucleotide sequences of amplified miRNAs were correct (Fig. 2) . MiRNAs from carcinoma cells and paired normal epithelial cells were separately extracted by LCM from FFPE tissue samples of 13 HNSCC, 10 ESCC, 5 skin SCC, 5 cervical SCC, 5 lung SCC, 5 lung adenocarcinoma and 5 colorectal adenocarcinoma patients. High expression (net intensity) of miR-205 was also observed in all HNSCC, ESCC, skin SCC, cervical SCC, 5 lung SCC tissue samples regardless of normal and malignant squamous epithelial cells, whereas no detectable level of the expression was observed in lung adenocarcinoma and normal or malignant colorectal epithelial cells (Fig. 3) . This confirmed miR-205 as a specific marker miRNA of squamous epithelium. Significant upregulation of miR-21 was also observed in HNSCC and ESCC tissues compared to the paired normal squamous epithelia (Fig. 4) . However, no statistically significant up-regulation of let-7a, miR-16 and miR-30a-5p was observed in HNSCC and ESCC tissue samples [p=0.1045, 0.4898 or 0.3315 (HNSCC) and p=0.0716, 0.3024 or 0.1238 (ESCC), respectively], although let-7a and miR-16 were statistically up-regulated in HNSCC and ESCC cell lines compared to the normal squamous epithelia derived from frozen sections by LCM (Fig. 1) . Since let-7a and miR-16 have been widely shown to function as tumorsuppressive miRNAs in B-cell lymphomas and colonic and lung cancers by controlling the translation of BCL2 and RAS oncogenes, respectively (6-9), our results suggested that miRNA expression and their target mRNAs of HNSCC and ESCC were quite different from those of other organ malignancies. Although miR-21 would be a putative oncogenic miRNA in HNSCC and ESCC similarly with other cancers, let-7a and miR-16 might not be a tumor suppressive miRNA in these SCC.
Discussion
MiRNAs are a new class of non-coding small RNAs that regulate cell proliferation and various cellular functions through interfering the translation of target mRNAs (4, 5) . Recent studies have demonstrated that altered expression of several miRNA induces various human malignancies (6-9). The expression profiles have been established for many different cancers and seem to be unique to each cancer (6-9). However, scarce data exist on the role of miRNAs in HNSCC and ESCC. In this study, we investigated the miRNA expression of malignant and normal squamous epithelia of oral cavity, the esophagus and other organs. The results revealed that miR-205 was highly expressed in both benign and malignant squamous epithelia, resulting in a potential specific marker miRNA of squamous epithelia. Also, we found that miR-21 might be an oncogenic miRNA similarlyto other organ malignancies, but miR-16 and let-7a might not function as tumor-suppressive miRNAs in HNSCC and ESCC differently from malignancies of other organs.
It has been recently reported that miR-205 was highly expressed in cell lines of HNSCC and ESCC compared to those of other organ malignancies (1,2,11). Fletcher et al reported that miR-205 was abundantly expressed in mouse tissues involving squamous epithelium as well as in HNSCC cell lines (12) . In this study, we have confirmed that miR-205 showed the highest expression in both benign and malignant squamous epithelial cell lines as well as in both epithelial cells obtained from FFPE tissue samples by LCM. Its function including target mRNAs in squamous epithelium has not yet been elucidated, but it might regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 in collaboration with miR-200 family miRNAs (13) and target the HER3 oncogene in human breast cancer (14) . Lipid phosphatase SHIP2 was reported to be one of the targets of miR-205 in corneal epithelium and the corneal epithelialspecific miR-184 could interfere with the ability of miR-205 to suppress SHIP2 levels (15) . It has been reported that lowlevel expression of miR-205 is a prognostic marker of HNSCC (16) . Since the present study demonstrated that miR-205 was specifically expressed in squamous epithelium but not in other types of epithelia, miR-205 might become a specific biomarker to distinguish SCC from other carcinomas. This might be useful to determine the cell origin of poorly differentiated or undifferentiated carcinomas as well as to ONCOLOGY REPORTS 23: 1625 -1633 , 2010 locate the primary site of metastatic carcinomas. In addition, Fletcher et al reported that miR-205 could be used for wholelymph node processing and qRT-PCR analysis to detect micrometastasis of SCC (12) . Although no apparent alteration was observed in the expression of miR-205 between normal and malignant squamous epithelium in this study, its consistent expression makes it reliable surrogate marker for the presence of squamous epithelium.
Of interest in our study is that miRNAs were successfully extracted from FFPE tissue samples and their application for histopathological diagnosis was confirmed, in addition to routine hematoxylin-eosin and immunohistochemical staining methods. MiRNAs are stable small molecules and not degraded even under heat-or acid-degenerative conditions (5) . Indeed, we could successfully extract abundant high-quality miRNAs detectable by RT-PCR from FFPE tissues stored at room temperature over 20 years (Fig. 2) . Thus, miRNAs took specific advantage compared to their target mRNAs, which are unstable and mostly degraded in FFPE tissue samples. However, there are only a few studies concerning the use of miRNA for molecular diagnosis in the histopathological fields. Our present study clearly demonstrated the usage of miR-205 as a squamous epithelial-specific marker in routinely processed FFPE tissue samples for histopathological diagnosis. If various specific miRNA markers are identified after this, molecular diagnosis using miRNA in routine FFPE tissue samples would come into wide use in most pathological laboratories, instead of molecular diagnosis using mRNA in frozen tissue samples.
Mir-21 has been investigated widely in various human malignancies including hematological malignancies and glioblastomas as a putative oncogenic miRNA (6) (7) (8) (9) 17, 18) . It has been also implicated in 5-FU resistance (19) , hypertrophic heart muscles (20) and vascular formation (21) . MiR-21 has been shown to act as an oncogenic miRNA by targeting tumor suppressor gene tropomyosin 1 (TPM1) (22) . Chan et al reported that miR-21 functions as an anti-apoptotic agent through activation of caspase by knockdown of miR-21 (18) . It has been shown that miR-21 was involved in invasion and metastasis (23) , modulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 (24) and regulation of STAT3-mediated pathway (25) . In the present study, miR-21 was also markedly up-regulated in HNSCC and ESCC tissues compared to paired normal squamous epithelia. Target mRNA of miR-21 in HNSCC and ESCC was not examined in this study, but it is likely that miR-21 inhibits several mRNAs leading to a cascade of events that prevent apoptosis and increase cellular proliferation.
Let-7a and miR-16 have also been widely studied as tumor-suppressive miRNAs. Let-7 family miRNAs including let-7a are down-regulated in various human malignancies and are shown to negatively regulate RAS oncogenes frequently activated in many cancers (6) (7) (8) (9) 26) . Down-regulation of let-7 family miRNAs is also shown to cause radioresistance and results in poor prognosis (27) . RAS oncogenes are frequently overexpressed without mutation in HNSCC and ESCC (28) . On the other hand, the expression of miR-16 induces apoptosis by targeting anti-apoptotic gene BCL2 and is down-regulated in many human malignancies including hematological cancer (6-9,29,30 ). However, in the present study, the expression of let-7a and miR-16 was not down-regulated and even tended to be up-regulated although without statistical significance in HNSCC. Tran et al also reported high expression of let-7a and miR-16 in several HNSCC cell lines (2) . The reason is unknown, but we assume that target mRNAs of these miRNAs might be different between SCC and other cancers such as adenocarcinomas and lymphoma/leukemia and might not be involved in the initiation and progression of HNSCC. Also, miR-30a-5p is not statistically altered in the validation study using clinical samples, although it is apparently up-regulated in the initial miRNA microarray using cell lines. This discrepancy might be due to the different cell sources used, in addition to unknown functions of this miRNA.
Several miRNAs other than those above mentioned have been reported to be involved in HNSCC and ESCC. It has been reported that high expression of mir-103/107 correlated with poor survival in ESCC (31) . MiR-184 has also been reported to act as a potential oncogenic miRNA in HNSCC (32) . However, miR-103/107 was not statistically altered between benign and malignant squamous epithelial cell lines, although these miRNAs showed relatively high expression both in benign and malignant squamous epithelial cell lines in our microarray analysis. MiR-184 showed low expression with no drastic alteration between benign and malignant squamous epithelia. Also, miR-133a, miR-133b, miR-137, miR-193a and miR-494 were less expressed in both benign and malignant squamous epithelial cell lines, although they have been reported to be down-regulated in HNSCC (2, 3, 32, 33) .
In summary, we examined the expression of miRNAs in HNSCC and ESCC and found two possible marker miRNAs in these cancers. MiR-205 might be a specific marker miRNA of both normal and malignant squamous epithelia, while miR-21 might be a putative oncogenic miRNA in HNSCC and ESCC. Further study for their use as histopathological diagnostic, prognostic or therapeutic marker is now undergoing in our laboratory.
